Lenalidomide, Bortezomib, and Dexamethasone with Transplantation in Myeloma.

BACKGROUND: High-dose chemotherapy with autologous stem cell transplantation has been the standard treatment for young patients with newly diagnosed myeloma. However, promising emerging data with the combination of lenalidomide, bortezomib and dexamethasone (RVD) have raised questions about the role...

全面介紹

Na minha lista:
書目詳細資料
發表在:N Engl J Med
Main Authors: Attal, Michel, Lauwers-Cances, Valerie, Hulin, Cyrille, Leleu, Xavier, Caillot, Denis, Escoffre, Martine, Arnulf, Bertrand, Macro, Margaret, Belhadj, Karim, Garderet, Laurent, Roussel, Murielle, Payen, Catherine, Mathiot, Claire, Fermand, Jean Paul, Meuleman, Nathalie, Rollet, Sandrine, Maglio, Michelle E., Zeytoonjian, Andrea A., Weller, Edie A., Munshi, Nikhil, Anderson, Kenneth C., Richardson, Paul G., Facon, Thierry, Avet-Loiseau, Hervé, Harousseau, Jean-Luc, Moreau, Philippe
格式: Artigo
語言:Inglês
出版: 2017
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201242/
https://ncbi.nlm.nih.gov/pubmed/28379796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1611750
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍